[artículo] 
inJournal of the American Academy of Child & Adolescent Psychiatry > Año 2017 - Vol. 56 - No.10 [18/12/2017] . - pp. 849-856

Título :	A Randomized, Placebo-Controlled Trial of Metformin for the Treatment of Overweight Induced by Antipsychotic Medication in Young People With Autism Spectrum Disorder : Open-Label Extension
Tipo de documento:	texto impreso
Autores:	Benjamin L. Handen, Autor ; Evdokia Anagnostou, Autor ; Michael G. Aman, Autor
Fecha de publicación:	2017
Artículo en la página:	pp. 849-856
Idioma :	Inglés (eng)
Palabras clave:	Metformina, Trastorno del Espectro Autista, Aumento de Peso, Medicación Antipsicótica.
Resumen:	A previous study reported on a 16-week placebo-controlled, randomized clinical trial (RCT) of metformin for weight stabilization in 61 children and adolescents 6 to 17 years old with autism spectrum disorder who were prescribed atypical antipsychotics.
Link:	./index.php?lvl=notice_display&id=9717

[artículo] A Randomized, Placebo-Controlled Trial of Metformin for the Treatment of Overweight Induced by Antipsychotic Medication in Young People With Autism Spectrum Disorder : Open-Label Extension [texto impreso] / Benjamin L. Handen, Autor ; Evdokia Anagnostou, Autor ; Michael G. Aman, Autor . - 2017 . - pp. 849-856.
Idioma : Inglés (eng)
in Journal of the American Academy of Child & Adolescent Psychiatry > Año 2017 - Vol. 56 - No.10 [18/12/2017] . - pp. 849-856

Palabras clave:	Metformina, Trastorno del Espectro Autista, Aumento de Peso, Medicación Antipsicótica.
Resumen:	A previous study reported on a 16-week placebo-controlled, randomized clinical trial (RCT) of metformin for weight stabilization in 61 children and adolescents 6 to 17 years old with autism spectrum disorder who were prescribed atypical antipsychotics.
Link:	./index.php?lvl=notice_display&id=9717